7.5 C
Glasgow
Friday, December 5, 2025
spot_img

More News

Protego Biopharma raises $130m for AL amyloidosis programme

Jim Cornall -
Protego Biopharma, Inc., a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule therapeutics that reprogramme protein folding to...

Belgian company looks to Uzbekistan to expand biotech footprint

Jim Cornall -
Deputy Minister of Investment, Industry and Trade of the Republic of Uzbekistan, Akram Aliyev, held a meeting with the...

New era in precision protein design?

Jim Cornall -
Galux, a South Korean biotech pioneering AI-driven protein therapeutics design, has announced new experimental findings demonstrating that its AI...

Results ‘approach Holy Grail’ of cancer research

Jim Cornall -
Lunai Bioworks has secured its first letter of intent (LOI) to license its next-generation immune cell therapy, which achieved...

Positive phase 1 Alzheimer’s disease data

Jim Cornall -
Swiss company Vandria SA has announced topline results from its first-in-human clinical trial of its lead central nervous system...

Patronus Biotech receives grant to evaluate novel malaria vaccine

Jim Cornall -
Singaporean company Patronus Biotech has received a grant from the Gates Foundation to accelerate the development of its novel...

Collaboration boosts cell therapy production

Jim Cornall -
NorthX Biologics, a leading CDMO and Swedish national innovation hub for advanced biologics, and Mendus, a Swedish-Dutch immuno-oncology company...

RSV vaccines could offer protection against asthma

Jim Cornall -
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered evidence that early-infancy infection with...

New digital health solution for early detection of epileptic seizures

Jim Cornall -
Neuraxpharm Group and mjn-neuro have announced the upcoming launch of EPISERAS, a digital health solution designed to predict the...

Base to Base biotech podcast 37: Life Sciences in Flanders, AI and drug discovery, and healthcare investment

admin -
This week, we have conversations with Jérôme Van Biervliet, chair of the board of Flanders life sciences body Biovia...

Faster and more reliable dementia diagnosis

Jim Cornall -
Researchers at Örebro University in Sweden have developed two new AI models that can analyse the brain's electrical activity...

Unstable protein understanding key to new treatments

Jim Cornall -
Around 80% of proteins involved in diseases like cancer and neurodegenerative illnesses do not have a stable structure. These...

New immune process identified that may alleviate Alzheimer’s disease

Jim Cornall -
Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer’s disease that clears toxic amyloid plaques...

Calcium-sensitive switch boosts cancer drugs’ efficacy

Jim Cornall -
Cancer-fighting antibody drugs are designed to penetrate tumour cells and release a lethal payload deep inside, but often they...

$120m investment to grow talent and innovation in Virginia

Jim Cornall -
A Memorandum of Understanding (MOU) signed by the Virginia Innovation Partnership Corporation (VIPC) and AstraZeneca, Eli Lilly (Lilly), and...

Potential of enzymatic single-stranded DNA for non-viral gene editing

Jim Cornall -
Moligo Technologies, a DNA synthesis company advancing gene therapies, has published an article in Nature Communications that demonstrates enzymatically...

The next era of CGT

Jim Cornall -
GenScript Biotech Corporation has hosted the GenScript Biotech Global Forum London 2025 in the UK. It is the forum's second...

FDA approves PADCEV plus Keytruda for certain patients with bladder cancer

Jim Cornall -
Pfizer Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV...

‘Groundbreaking’ rapid diagnostic test for prostate cancer

Jim Cornall -
A Welsh diagnostics company is developing a test it describes as ‘groundbreaking,’ which could detect prostate cancer in men...

Breakthrough in cancer immunotherapy using marine bacteria

Jim Cornall -
A research team led by Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute...

Trial results could shorten TB treatment time

Jim Cornall -
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media